Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
1.390
-0.010 (-0.71%)
At close: Dec 5, 2025, 4:00 PM EST
1.410
+0.020 (1.44%)
After-hours: Dec 5, 2025, 7:05 PM EST
Zentalis Pharmaceuticals Employees
Zentalis Pharmaceuticals had 166 employees as of December 31, 2024. The number of employees decreased by 2 or -1.19% compared to the previous year.
Employees
166
Change (1Y)
-2
Growth (1Y)
-1.19%
Revenue / Employee
$161,837
Profits / Employee
-$899,494
Market Cap
100.43M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ZNTL News
- 25 days ago - Zentalis Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operational Progress - GlobeNewsWire
- 4 weeks ago - Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - Zentalis Pharmaceuticals Announces Four Azenosertib Posters Presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - GlobeNewsWire
- 3 months ago - Zentalis Pharmaceuticals, Inc. (ZNTL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 3 months ago - Zentalis Pharmaceuticals Appoints James B. Bucher, JD, as Chief Legal Officer and Corporate Secretary - GlobeNewsWire
- 4 months ago - Zentalis (ZNTL) Q2 Loss Narrows 70% - The Motley Fool
- 4 months ago - Zentalis Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational Progress - GlobeNewsWire